Not all people with CLL involve therapy. Inspite of all new advances, the iwCLL continue to suggests watchful observation for patients with asymptomatic disorder.86 This suggestion is based on at least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Nikmati sensasi t